Jianxing He
Clinical trials sponsored by Jianxing He, explained in plain language.
-
Surgery before chemo and immunotherapy may boost lung cancer outcomes
Disease control Not yet recruitingThis study looks at whether surgically removing the primary lung tumor before giving immunotherapy (sintilimab) and chemotherapy can improve outcomes for people with advanced non-small cell lung cancer that is not driven by EGFR or ALK mutations. About 118 participants will be ra…
Phase: PHASE2 • Sponsor: Jianxing He • Aim: Disease control
Last updated Jun 26, 2026 18:22 UTC
-
Can removing the main tumor boost targeted therapy in advanced lung cancer?
Disease control Not yet recruitingThis study looks at whether surgically removing the primary lung tumor before starting the targeted drug osimertinib can help people with advanced EGFR-mutant non-small cell lung cancer. About 118 patients with stage III-IV cancer will be randomly assigned to get surgery plus osi…
Phase: PHASE2 • Sponsor: Jianxing He • Aim: Disease control
Last updated Jun 26, 2026 18:21 UTC
-
Smart device aims to boost lung recovery after cancer surgery
Symptom relief Not yet recruitingThis study tests a smart breathing exercise device for people recovering from lung cancer surgery. About 200 adults will either use the device for 30 days after surgery or receive standard care. The goal is to see if the device improves lung function, reduces shortness of breath,…
Phase: NA • Sponsor: Jianxing He • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Breathing Tube-Free anesthesia could speed kidney transplant recovery
Symptom relief Not yet recruitingThis study compares a new 'tubeless' anesthesia method (using a laryngeal mask and lighter sedation) to standard breathing-tube anesthesia in 60 kidney transplant patients. The goal is to see if it reduces the need for muscle relaxants and other drugs, and improves recovery. Part…
Phase: NA • Sponsor: Jianxing He • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC